Skip to main content Skip to office menu Skip to footer
Capital IconMinnesota Legislature
Office of the Revisor of Statutes

HF 4966

as introduced - 93rd Legislature (2023 - 2024) Posted on 03/14/2024 02:34pm

KEY: stricken = removed, old language.
underscored = added, new language.
Version List Authors and Status
Pdf Rtf

Bill Text Versions

Engrossments
Introduction Posted on 03/14/2024 ,  79 occurences of "cannabis"

Current Version - as introduced

Line numbers 1.1 1.2 1.3 1.4
1.5 1.6 1.7 1.8 1.9 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 1.18 1.19 1.20 1.21 2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 2.9 2.10 2.11 2.12 2.13 2.14 2.15 2.16 2.17 2.18 2.19 2.20 2.21 2.22 2.23 2.24 2.25 2.26 2.27 2.28 2.29 2.30 2.31 2.32 2.33 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 3.9 3.10 3.11 3.12 3.13 3.14 3.15 3.16 3.17 3.18 3.19 3.20 3.21 3.22 3.23 3.24 3.25 3.26 3.27 3.28 3.29 3.30 3.31 3.32 4.1 4.2 4.3

A bill for an act
 relating to cannabis Next ; modifying medical Previous cannabis Next combination business provisions;
amending Minnesota Statutes 2023 Supplement, section 342.515.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

Section 1.

Minnesota Statutes 2023 Supplement, section 342.515, is amended to read:


342.515 MEDICAL Previous CANNABIS Next COMBINATION BUSINESSES.

Subdivision 1.

Authorized actions.

A medical Previous cannabis Next combination business license
entitles the license holder to perform any or all of the following within the limits established
by this section:

(1) grow Previous cannabis Next plants from seed or immature plant to mature plant and harvest
adult-use Previous cannabis Next flower and medical Previous cannabis Next flower from a mature plant;

(2) make Previous cannabis Next concentrate;

(3) make hemp concentrate, including hemp concentrate with a delta-9
tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;

(4) manufacture artificially derived cannabinoids;

(5) manufacture medical cannabinoid products;

(6) manufacture adult-use Previous cannabis Next products, lower-potency hemp edibles, and
hemp-derived consumer products for public consumption;

(7) purchase immature Previous cannabis Next plants and seedlings and Previous cannabis Next flower from a Previous cannabis Next
microbusiness, a Previous cannabis Next mezzobusiness, a Previous cannabis Next manufacturer, a Previous cannabis Next wholesaler,
a medical Previous cannabis Next cultivator, or another medical Previous cannabis Next combination business;

(8) purchase hemp plant parts and propagules from an industrial hemp grower licensed
under chapter 18K;

(9) purchase Previous cannabis Next concentrate, hemp concentrate, and artificially derived cannabinoids
from a Previous cannabis Next microbusiness, a Previous cannabis Next mezzobusiness, a Previous cannabis Next manufacturer, a
Previous cannabis Next wholesaler, a medical Previous cannabis Next processor, or another medical Previous cannabis Next combination
business;

(10) purchase hemp concentrate from an industrial hemp processor licensed under chapter
18K;

(11) new text begin manufacture, new text end packagenew text begin ,new text end and label medical Previous cannabis Next and medical cannabinoid products
for sale to medical Previous cannabis Next processors, medical Previous cannabis Next retailers, other medical Previous cannabis Next
combination businesses, and patients enrolled in the registry program, registered designated
caregivers, and parents, legal guardians, and spouses of an enrolled patient;

new text begin (12) transport and deliver medical Previous cannabis Next and medical cannabinoid products to medical
Previous cannabis Next processors, medical Previous cannabis Next retailers, other medical Previous cannabis Next combination
businesses, patients enrolled in the registry program, registered designated caregivers, and
parents, legal guardians, and spouses of an enrolled patient;
 new text end

deleted text begin (12)deleted text end new text begin (13) manufacture,new text end packagenew text begin ,new text end and label adult-use Previous cannabis Next flower, adult-use Previous cannabis Next
products, lower-potency hemp edibles, and hemp-derived consumer products for sale to
customersnew text begin and other Previous cannabis Next businessesnew text end ;

deleted text begin (13)deleted text end new text begin (14)new text end sell medical Previous cannabis Next flower and medical cannabinoid products to new text begin Previous cannabis Next
processors, medical Previous cannabis Next retailers, other medical Previous cannabis Next combination businesses, and
new text end patients enrolled in the registry program, registered designated caregivers, and parents, legal
guardians, and spouses of an enrolled patient;

deleted text begin (14)deleted text end new text begin (15)new text end sell immature Previous cannabis Next plants and seedlings, adult-use Previous cannabis Next flower, adult-use
Previous cannabis Next products, lower-potency hemp edibles, hemp-derived consumer products, and
other products authorized by law to other Previous cannabis Next businesses and to customers; deleted text begin and
deleted text end

new text begin (16) transport and deliver immature Previous cannabis Next plants and seedlings, adult-use Previous cannabis Next
flower, adult-use Previous cannabis Next products, lower-potency hemp edibles, hemp-derived consumer
products, and other products authorized by law to other Previous cannabis Next businesses and to customers;
and
 new text end

deleted text begin (15)deleted text end new text begin (17)new text end perform other actions approved by the office.

Subd. 2.

Cultivation; size limitations.

(a) A medical Previous cannabis Next combination business
may cultivate Previous cannabis Next deleted text begin to be sold as medical Previous cannabis Next flower or used in medical cannabinoid
productsdeleted text end in an area of up to deleted text begin 60,000deleted text end new text begin 90,000new text end square feet of plant canopy.new text begin A medical Previous cannabis Next
combination business may cultivate Previous cannabis Next and manufacture Previous cannabis Next at more than one
location, but the aggregate total area of plant canopy in all locations must count toward the
business's canopy limit.
new text end

deleted text begin (b) A medical Previous cannabis Next combination business may cultivate Previous cannabis Next to be sold as
adult-use Previous cannabis Next flower or used in adult-use Previous cannabis Next products in an area authorized by
the office as described in paragraph (c).
 deleted text end

deleted text begin (c) The office shall authorize a medical Previous cannabis Next combination business to cultivate
Previous cannabis Next for sale in the adult-use market in an area of plant canopy that is equal to one-half
of the area the business used to cultivate Previous cannabis Next sold in the medical market in the preceding
year. The office shall establish an annual verification and authorization procedure.deleted text end new text begin (b)new text end The
office may increase the area of plant canopy in which a medical Previous cannabis Next combination
business is authorized to cultivate Previous cannabis Next deleted text begin for sale in the adult-use market between
authorization periodsdeleted text end if the business demonstrates a deleted text begin significant increase in the sale of medical
Previous cannabis Next and medical Previous cannabis Next productsdeleted text end new text begin legitimate need for the additional plant canopy to
satisfy demand in either the medical Previous cannabis Next or adult-use Previous cannabis Next marketnew text end .

Subd. 3.

Manufacturing; size limitations.

The office may establish limits on Previous cannabis Next
manufacturing that are consistent with the area of plant canopy a business is authorized to
cultivate.

Subd. 4.

Retail locations.

A medical Previous cannabis Next combination business may operate up to
one retail location in each congressional district. A medical Previous cannabis Next combination business
must offer medical Previous cannabis Next flower, medical cannabinoid products, or both at every retail
location.

Subd. 5.

Failure to participate; suspension or revocation of license.

new text begin A medical Previous cannabis Next
combination business shall provide a reliable and ongoing supply of medical Previous cannabis Next to
the registry program through cultivation by the manufacturer or the purchase of Previous cannabis Next
flower and medical cannabinoid products. new text end The office may suspend or revoke a medical
Previous cannabis Next combination business license if the office determines that the business is no longer
actively participating in the medical Previous cannabis Next market. The office may, by rule, establish
minimum requirements related to Previous cannabis Next cultivation, manufacturing of medical cannabinoid
products, retail sales of medical Previous cannabis Next flower and medical cannabinoid products, and
other relevant criteria to demonstrate active participation in the medical Previous cannabis Next market.

Subd. 6.

Operations.

A medical Previous cannabis combination business must comply with the
relevant requirements of sections 342.25, 342.26, 342.27,new text begin 342.35, 342.41, 342.42,new text end and
342.51, subdivisions 2 to 5.